Skip to main content
Log in

Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

We investigated telomere length changes in patients with non-Hodgkin's lymphoma (NHL) receiving conventional-dose chemotherapy. Using Southern blot analysis, telomere length was measured in peripheral blood mononuclear cells from five NHL patients at diagnosis, 15 NHL patients after chemotherapy, and 39 healthy controls. Compared with age-matched putative normal controls, telomeres were significantly shorter in NHL patients at diagnosis. Mean telomere length was shorter after chemotherapy than before chemotherapy and was shorter after chemotherapy than in age-matched putative healthy controls. There was no correlation between the extent of telomere shortening and time elapsed after chemotherapy. These findings suggest that in NHL patients hematopoietic stem cells lose telomere length during the recovery period from bone marrow suppression after conventional-dose chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Blackburn EH (1991) Structure and function of telomeres. Nature 350:569–573

    Article  CAS  PubMed  Google Scholar 

  2. Zakian VA (1995) Telomeres: beginning to understand the end. Science 270:1601–1607

    Article  CAS  PubMed  Google Scholar 

  3. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL, Wu JR (1988) A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 85:6622–6626

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Blackburn EH (1994) Telomeres: no end in sight. Cell 77:621–623

    Article  CAS  PubMed  Google Scholar 

  5. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 91:9857–9860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Nat Acad Sci U S A 89:10114–10118

    Article  CAS  Google Scholar 

  7. Slagboom PE, Droog S, Boomsma DI (1994) Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Gen 55:876–882

    CAS  Google Scholar 

  8. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA (1997) Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90:182–193

    CAS  PubMed  Google Scholar 

  9. Frenck RW Jr, Blackburn EH, Shannon KM (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc Nat Acad Sci U S A 95:5607–5610

    Article  CAS  Google Scholar 

  10. Shay JW (1998) Accelerated telomere shortening in bone-marrow recipients. Lancet 351:153–154

    Article  CAS  PubMed  Google Scholar 

  11. Wynn RF, Cross MA, Hatton C, Will AM, Lashford LS, Dexter TM, Testa NG (1998) Accelerated telomere shortening in young recipients of allogeneic bone marrow transplants. Lancet 351:178–181

    Article  CAS  PubMed  Google Scholar 

  12. Lee J, Kook H, Chung I, Kim H, Park M, Kim C, Nah J, Hwang T (1999) Telomere length changes in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 24:411–415

    Article  CAS  PubMed  Google Scholar 

  13. Rufer N, Brummendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E (2001) Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 97:575–577

    Article  CAS  PubMed  Google Scholar 

  14. Schroder CP, Wisman GB, de Jong S, van der Graaf WT, Ruiters MH, Mulder NH, de Leij LF, van der Zee AG, de Vries EG (2001) Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer 84:1348–1353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S, Moore MA (1998) Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 12:13–24

    Article  CAS  PubMed  Google Scholar 

  16. Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD Jr (1996) Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. J Clin Oncol 14:565–571

    Article  CAS  PubMed  Google Scholar 

  17. Lee JJ, Kim HJ, Chung IJ, Park MR, Ryang DW, Choi C (2001) Secondary myeloid/natural killer cell acute leukemia following T-cell lymphoma. Leuk Lymphoma 41:457–460

    Article  CAS  PubMed  Google Scholar 

  18. Travis LB, Curtis RE, Boice JD Jr, Hankey BF, Fraumeni JF Jr (1991) Second cancers following non-Hodgkin's lymphoma. Cancer 67:2002–2009

    Article  CAS  PubMed  Google Scholar 

  19. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1997) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17:3835–3849

    Article  Google Scholar 

  20. Lee JJ, Kook H, Chung IJ, Na JA, Park MR, Hwang TJ, Kwak JY, Sohn SK, Kim HJ (2001) Telomere length changes in patients with aplastic anaemia. Br J Haematol 112:1025–1030

    Article  CAS  PubMed  Google Scholar 

  21. de Lange T (1998) Length control of human telomeres. Cancer J Sci Am 4:S22–S25

    Google Scholar 

  22. Watson JD (1972) Origin of concatemeric T7 DNA. Nat New Biol 239:197–201

    Article  CAS  PubMed  Google Scholar 

  23. Hagemeister FB (2002) Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Cancer Chemother Pharmacol 49:S13–20

    Article  CAS  PubMed  Google Scholar 

  24. Chen HJ, Liang CL, Lu K, Lin JW, Cho CL (2000) Implication of telomerase activity and alterations of telomere length in the histological characteristics of intracranial meningiomas. Cancer 89:2092–2098

    Article  CAS  PubMed  Google Scholar 

  25. Remes K, Norrback KF, Rosenquist R, Mehle C, Lindh J, Roos G (2000) Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer 82:601–607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wu K, Lund M, Bang K, Thestrup-Pedersen K (1999) Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer 86:1056–1063

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6–01GN16–0005).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.-J. Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JJ., Nam, CE., Cho, SH. et al. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol 82, 492–495 (2003). https://doi.org/10.1007/s00277-003-0691-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-003-0691-4

Keywords

Navigation